SPARSOMYCIN AND ITS ANALOGS - A PRECLINICAL STUDY ON NOVEL ANTICANCER DRUGS

被引：1
|
作者：
ZYLICZ, Z [1 ]
机构：
[1] ST RADBOUD UNIV HOSP,DEPT MED ONCOL,6500 HB NIJMEGEN,NETHERLANDS
来源：
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION | 1989年 / 11卷 / 02期
关键词：
D O I：
10.1007/BF01962978
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [1] Celecoxib analogs that lack COX-2 inhibitory function:: preclinical development of novel anticancer drugs
    Schoenthal, Axel H.
    Chen, Thomas C.
    Hofman, Florence M.
    Louie, Stan G.
    Petasis, Nicos A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (02) : 197 - 208
  • [2] SIMULATION STUDY OF PRECLINICAL DEVELOPMENT OF ANTICANCER DRUGS
    GORDON, MH
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1974, 5 (01): : 65 - 78
  • [3] Preclinical evaluation of anticancer drugs
    Lavelle, F
    BULLETIN DU CANCER, 1998, 85 (10) : 837 - 842
  • [4] Potential and promising anticancer drugs from adenosine and its analogs
    Man, Shuli
    Lu, Yingying
    Yin, Lijuan
    Cheng, Xinkuan
    Ma, Long
    DRUG DISCOVERY TODAY, 2021, 26 (06) : 1490 - 1500
  • [5] Analogs of staurosporine: Potential anticancer drugs?
    Gescher, A
    GENERAL PHARMACOLOGY, 1998, 31 (05): : 721 - 728
  • [6] THE SYNTHESIS, BIOCHEMISTRY, AND BIOLOGICAL-ACTIVITY OF NOVEL PHENOLIC SPARSOMYCIN ANALOGS
    FLYNN, GA
    ASH, RJ
    BITONTI, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 193 : 67 - MEDI
  • [7] ANTITUMOR-ACTIVITY OF SPARSOMYCIN (SM, NSC 59729) AND ITS ANALOGS
    ZYLICZ, Z
    WAGENER, DJT
    VANRENNES, H
    VANDERKLEIJN, E
    VANDENBROEK, LAGM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 84 - 84
  • [8] Methodogy for preclinical research on new anticancer drugs
    Debussche, L
    BULLETIN DU CANCER, 2001, 88 (01) : 67 - 74
  • [9] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge J.J.
    Ahn C.-H.
    Andrews P.A.
    Brower M.E.
    Giorgio D.W.
    Goheer M.A.
    Lee-Ham D.Y.
    McGuinn W.D.
    Schmidt W.
    Sun C.J.
    Tripathi S.C.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (3) : 173 - 185
  • [10] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge, JJ
    Ahn, CH
    Andrews, PA
    Brower, ME
    Giorgio, DW
    Goheer, MA
    Lee-Ham, DY
    McGuinn, WD
    Schmidt, W
    Sun, CJ
    Tripathi, SC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (03) : 173 - 185
12345